http://www.socialaudit.org.uk/5111-005.htm
"....The strategy for DTCA used by the Association of the British Pharmaceutical Industry (ABPI) has been enacted throughout Europe, especially in the major drug-producing countries. The ‘Battle Plan’, was described in a private meeting by the Director-General of the ABPI, and reported in the trade journal, Pharmaceutical Marketing, as follows:
"Now the ABPI has announced that it is launching the final stages of a campaign before it tackles the Government and the EU head on ... It is the spearhead of a carefully thought-out campaign. The ABPI battle plan is to employ ground troops in the form of patient support groups, sympathetic medical opinion and healthcare professionals - known as 'stakeholders' - which will lead the debate on the informed patient issue. This will have the effect of weakening political, ideological and professional defences … Then the ABPI will follow through with high-level precision strikes on specific regulatory enclaves in both Whitehall and Brussels." (Jeffries, 2000)[v] ..."
And now the plan has been implemented in the UK and Europe and they possess more power than we can possibly imagine, the ABPI plays the 'innocent party' in disease mongering?
Too funny 
